<DOC>
	<DOCNO>NCT01454401</DOCNO>
	<brief_summary>The LeucoPatch™ study goal investigate whether fully autologous growth factor-containing dressing LeucoPatch™ positive effect heal rate diabetic foot ulcer . The study seek gather data comparison previous data similar wound ( historical control ) . By subgrouping treat wound ( similar historical control use ) assessment patient wound-related factor might indicate beneficial effect LeucoPatch™ seek .</brief_summary>
	<brief_title>LeucoPatch™ Study A Multicenter Study Effect LeucoPatch™ Diabetic Foot Ulcers</brief_title>
	<detailed_description>Summary : Treatment Study The goal LeucoPatch ™ study investigate effect LeucoPatch ™ diabetic foot ulcer . LeucoPatch ™ biologically active dressing make solely patient 's blood ( autologous ) . It produce CE ( European Conformity ) mark LeucoPatch™ Device contain additive . In treatment study 75 typical diabetic patient foot ulcer include . These wound typically chronic lead reduce quality life ability work , extensive treatment cost . Furthermore , wound often lead amputations.The study multicenter study 10 wound clinic expect involved . The primary endpoint time complete healing , secondary endpoint change wind size .</detailed_description>
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Diabetic Foot</mesh_term>
	<mesh_term>Foot Ulcer</mesh_term>
	<criteria>Age &gt; 18 year Type I Type II Diabetes Age wound &gt; 6 week Wound area &lt; 10 cm2 Wounds : Texas degree ≤ type IIa Perfusion status : toe pressure &gt; 30 mmHg , transcutaneous oxygen measurement ( TcPO2 ) &gt; 30 mmHg foot ( measure within last 3 month ) palpable foot pulse ( equivalent &gt; 60 mmHg ) Diabetes control : HbA1c &lt; 12 % Adequate offloading ( Walker , therapy sandal etc . ) The patient adhere treatment protocol expect conclude study Written inform consent NonDanish Swedish speaking Dementia Pregnant nursing woman The patient tolerate blood donation Hemoglobin : &lt; 6,5 mmol/l 105 g/l Haemophilia , Sickle cell anemia , severe thrombocytopenia , leukemia blood dyscrasia . Patient dialysis Clinical sign infection include osteomyelitis ( probe bone ) . Necrosis wind 40 % change ( +/ ) ulcer area 2week runin period optimal therapy . Blood vessel reconstruction within last 4 week . Participation clinical wound heal study last 30 day . Failure comply study protocol 2week runin period .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>